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Microarray Data from a
Statistician’s Point of View
Johanna Hardin

R

eports in the news often tell about how genes
determine the chances of getting a particular disease
or how a genetic mutation can increase susceptibility
to certain environmental changes. For example, Familial
Adenomatous Polyposis (FAP) is a type of colon cancer
that affects one in 8,000 people in the United States.
FAP is caused by a mutation in the adenomatous polyposis
coli (APC) gene. It has been estimated that a person with
FAP has over three times the relative risk of dying than a
person without FAP (Nugent et al. 1993).
It is well known that the DNA in a cell’s nucleus
contains the instructions for building proteins. A gene
is a segment of DNA that contains the instructions for
building a specific protein. If different genes are active,
then different proteins will be produced in a cell. Skin
cells are different from muscle cells, for example,
because different proteins are present in the two
different types of cells. When a gene is active in a cell,
we say that the gene is “expressed.” Information about
genetic activity can give insight into biologic processes
and cell behavior—both normal and cancerous.
Measuring genetic activity is the role of molecular
biologists. Until recently, scientists analyzed gene activity one gene at a time. Now activity can be measured
on tens of thousands of genes simultaneously using
a new tool known as a DNA microarray (Eisen and
Brown, 1999). Interpreting the gene expression data is
the role of statisticians. The huge volume of data from
microarray analyses brings new statistical challenges
and the need for new analytical techniques.
As statisticians, our role in many scientific fields,
particularly in the field of molecular biology, is vital and
fascinating. Because microarray data analysis is a new
and expanding research area, I cannot hope to cover
in this article all of the current research associated with
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microarray analysis. So my goal is to give an overview
of the analysis process and the related statistical issues.

Why Microarrays?
Information (that can be obtained from microarrays)
about genes helps us answer a myriad of biological
questions:
• What genetic differences are there between
healthy people and people with a particular disease?
• Are there genetic subgroups of people with a
particular disease who respond positively to a given
treatment?
• What kinds of genetic changes happen across
time or after frequent doses of a treatment?
• Which genes are co-regulated—have expression
levels that increase or decrease concurrently—in a
particular biological system?
• What is the likelihood of acquiring a particular
disease, given a person’s genetic make-up?

What is a Microarray?
DNA microarrays, first introduced commercially in
1996, come in a variety of forms, but they all contain
the same basic design. Each microarray consists of
thousands of single strands of genetic material tethered
to a “chip” the size of a thumbprint. The chips (which
are not reusable and should not be confused with
computer chips that can store and restore information)
are produced at numerous academic and research
laboratories, and they are also produced commercially.
Microarray technology uses a fundamental property
of DNA called “complementary base pairing.” Our DNA
gives the blueprint for the functioning of the cell written
in sequences of chemical bases: adenine (A), cytosine
(C), guanine (G), and thymine (T). These bases bind
in a double helix structure to create the DNA molecule
(See Figure 1). At each rung along the DNA ladder, A
always binds with T, and C always binds with G. Thus
A is complementary to T, and C is complementary to
G. Each spiral strand is connected to a complementary
ASA

strand by the paired bases. A subsequence of the gene
characterized by TGAAACT on one strand would have
ACTTTGA on the complementary strand of the DNA
molecule.

Base Pairs

Sugar Phosphate
Backbone

Adenine

Guanine

Thymine

Cytosine

Figure 1. Illustration of the DNA double helix molecule showing the
complementary base pairing on the rungs of the DNA ladder.

The DNA code is identical in each cell nucleus
through the entire body. However, in order for cells
to function appropriately, each different cell type
receives a different message from the DNA. A segment
of DNA is converted into an intermediary form known
as messenger RNA (mRNA) that exits the nucleus and
serves as a template for building proteins.
Consequently, we could determine which genes
are expressed in a cell by measuring the quantity of
mRNA there is in the cell corresponding to that gene.
However, free mRNA in a cell is very unstable, so it is
treated with an enzyme to convert the mRNA back into
DNA. This form of DNA is known as complementary
DNA (cDNA).
Through a denaturing process the double-stranded
DNA molecules in the sample are unzipped down
the middle into two single-stranded molecules. The
microarray chip itself also contains single strands of
genes that will attract the single gene strands from the
sample. The single strands from the sample will bind
with the single strands on the microarray chip to reform
the DNA double helix.
ASA

In a microarray experiment, the test sample is
labeled with a dye and a reference sample is labeled
with a dye of a different color. The reference sample
serves as a control to which the gene expression in the
test sample is compared. For instance, if we wanted
to determine which genes are expressed in a tumor
sample, we could use a tissue sample from a healthy
individual as the reference sample. We would then
compare the expression level of each gene in the tumor
sample to the expression level of each gene in the
reference sample. Suppose the tumor sample had been
labeled with a red dye and the reference sample had
been labeled with a green dye. Then a red spot on the
microarray would indicate that the gene corresponding
to that spot is expressed at a higher level in the tumor
sample than in the reference sample. Similarly, a green
spot would indicate that the gene is expressed at a
lower level in the tumor sample.
There are several techniques for constructing DNA
microarrays (Schena et al. 1995; Velculescu et al. 1995;
Lockhart et al. 1996). Though there are slight differences
in the microarray technologies, one basic outline of the
microarray procedure can be summarized as follows:
1. Label the sample with a fluorescent dye.
2. Isolate the cDNA from the cells of interest, e.g.,
tumor cells, plasma cells, etc.
3. Denature the sample so that the cDNA are in
single strands instead of the double helix form.
4. Place the sample onto the microarray chip and
allow the double helix structure to restore itself.
5. Wash the remaining sample off the chip so only
the parts of the sample that have bound to the
chip remain.
6. Scan the microarray chip with a laser to quantify
the fluorescence of each individual gene. The
more of the sample that is stuck to the chip, the
higher the fluorescence.
A. Malcolm Campbell at Davidson College has put
together an animation of the microarray process which
can be seen at website: www.bio.davidson.edu/courses/
genomics/cgip/chip/html.
In general, the amount of activity of a gene is
represented by the number of replicates of that gene in
a particular sample of cells. A high fluorescence level
indicates that multiple copies of a gene have bound to
the chip and that the gene has high activity in the cell.
Similarly, a low fluorescence level indicates low activity
of the gene in the cell. By quantifying the fluorescence,
the gene activity can be compared across different
samples, e.g., a group of healthy samples compared to
a group of tumor samples.
A sample scan of part of a chip is shown in Figure 2
(see page 6). The image shown in the figure is only part
of the chip. Each spot represents a gene and there are
thousands of genes on a chip. A red spot indicates that
sample 1 (the “red” sample) has high genetic activity
for that gene. A green spot indicates that sample 2
(the “green” sample) has high genetic activity for that
gene. The yellow spots indicate the genes where the
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the genes that are just barely expressed. Note genes
RPS11b and YBR124W, for example.
Additionally, by taking the ratio of intensities we
can identify the genes that are most highly expressed
in the treatment sample relative to the control sample
and vice versa. Taking the logarithm of the ratio helps
to further distinguish the genes with the highest and
lowest relative expression levels. Note genes HSP26 and
YRO2, for example.

What is the Statistician’s Role?

Figure 2. Part of a microarray chip. Each spot represents one
gene and the color represents the activity level of the gene in the
test sample.

two samples have similar activity, and the black spots
indicate where there is no activity.
An example of some microarray data is given in
Table 1. The data came from an experiment on aging
yeast in Laura Hoopes’ lab at Pomona College. The test
sample (treatment) contains older yeast cells, while the
reference sample (control) contains younger yeast cells.
The test sample was dyed red and the reference sample
was dyed green. The table only shows the expression
level of ten genes as an illustration. In an actual analysis
there would be data for many more genes.
From the numerical values we can identify the genes
that are highly expressed overall in the experiment and
Gene

Red
Intensity

Green
Intensity

Ration of
Intensities

Log 2 of
Ratio

YBR124W

92

78

1.179

0.238

YBR100W

103

77

1.338

0.420

MRS5

369

357

1.008

0.012

3423

2663

1.285

0.362

YBR075W

196

133

1.474

0.559

HSP26

805

175

4.600

2.202

VAP1

158

175

0.903

-0.147

YRO2

118

373

0.316

-1.660

125

135

0.926

-0.111

3855

3739

1.031

0.044

ECM33

YBR051W
RPS11B

Table 1. Sample microarray data from an experiment on aging
yeast cells. Red intensity refers to the test sample and green
intensity refers to the reference sample. The ratio of intensities tells
us the multiplicative change and the log base-2 ratio gives the
difference of the data after a log transformation. Data courtesy of
Laura Hoopes of Pomona College.
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Although it is preferable for the statistician to have
a hand in the experimental design, the statistician often
comes into a microarray analysis project once the data
have been collected. The statistician’s job is to use the
numerical fluorescence levels to make claims about the
populations of interest. Of course, the methodology will
depend on the question at hand. The computations can
be broken down into two main parts: data cleaning and
data analysis.
Though the microarray construction seems
straightforward in theory, in reality there are numerous
sources of variation. For example:
• Spots that are not systematically placed on the chip,
• Samples that smear outside of the measurement
surface,
• Dyes that fluoresce at different levels (green is
“stronger” than red), or
• Arrays with a variable amount of dye.
To address these problems, the data cleaning
step involves image processing, normalization, and
standardization. Current research on all three cleaning
steps is active and growing. In this article I focus on
data analysis instead of data cleaning, assuming the data
are already “clean.” Many software programs designed for
microarray analysis give options for cleaning the data.

Figure 3. Plot from the SAM analysis for the MM versus MGUS
comparison. Each dot represents a particular gene. The xcoordinate is the observed value of the test statistic and the
y-coordinate is the expected value of the test statistics under
hundreds of permutations. The dotted boundary is the cutoff for
significance given a specified false discovery rate.

ASA

What is an Example of Microarray
Analysis?
To illustrate some of the typical statistical techniques
applied to microarray data, let’s examine a real data
set from a particular type of commercial chip—
Affymetrix (version 5). The samples were taken from
three populations: a group with multiple myeloma (a
blood cancer abbreviated MM), a group with signs of
developing MM (abbreviated MGUS for “monoclonal
gammopothy of undetermined significance”), and a
healthy group.
In this situation, plasma cells from each of the test
subjects were isolated and placed on a microarray chip
since multiple myeloma is characterized by plasma
cells replicating out of control, which in turn causes
organ damage. The Affymetrix chip measures 12,625
genes simultaneously. There were 218 MM samples,
21 MGUS samples, and 45 healthy samples. The data
were collected at the Donna D. and Donald M. Lambert
Laboratory of Myeloma Genetics, University of Arkansas
for Medical Sciences by John Shaughnessy, Jr., and his
colleagues (Zhan et al. 2002).

those genes that are significant using both types of
comparisons.
Other methods have been developed to compare
two groups in the context of microarray data. Some
researchers have used a modification of the t-test
(Golub et al. 1999). Researchers at Stanford University
have developed a software package (SAM—Significant
Analysis of Microarrays) to conduct a permutations
test to establish cutoffs for the pairwise comparisons
(Tusher et al. 2001; Tibshirani et al. 2002).
The SAM technique applied to the MM versus
MGUS data identified 229 genes as showing significant
activity. The false discovery rate (FDR) was only about
three genes based on hundreds of random permutations
of the gene values. Figure 3 (see page 6) shows an
output plot from the SAM analysis.
For comparison, Table 2 presents the results of the
t-test, the Wilcoxon test, and the SAM method.
Number of Significant Genes
(p < 0.001)
Comparison

t-Test

MM versus
MGUS

422

What Statistical Techniques Can We Use?
The tools from basic statistics can be used to address
many microarray research questions; however, each
research hypothesis requires a different statistical tool.

Comparing Two Groups
Probably the most common research question
associated with microarray data is the two group
comparison: What differences in genetic activity are there
between one group of samples and another group of
samples? Usually the first group of samples comes from
people with a particular disease and the second group
comes from healthy people. We’d like to know what type
of genetic activity differentiates the two groups.
For example, we might be interested in comparing
the MM group with the MGUS group. The t-test from
basic statistics can be used to test whether the means of
the two populations are the same. By applying the t-test
separately to each of the 12,625 genes on the chip, we
can tell which genes have an average gene expression
that is different between the two groups. In the multiple
myeloma example the t-test found 422 gene comparisons
with p-values less than 0.001. Such a p-value indicates
that the probability is less than one in a thousand that
the difference occurred simply by chance.
When the t-test is not appropriate (when the data
are not normally distributed, for example), we could
use the Wilcoxon rank sum method to test whether
the median expression levels are the same in the
two populations. In the multiple myeloma example
the Wilcoxon rank sum test found 341 gene comparisons
with p-values less than 0.001. In comparing the MGUS
and MM samples, the intersection of the genes
with p-values less than 0.001 for both the t-test and
the Wilcoxon rank sum test was a set of 269 genes.
One analysis approach is to investigate further only
ASA

Wilcoxon Rank
SAM
By Chance
Sum Test
(FDR=3/229)
341

229

12.63

Table 2. The number of genes judged by each method to have a
statistically significant expression level in comparing the MM and
MGUS groups. Note that with α = .001 there could have been
12.63 genes identified as significant simply by chance even if
there was no effect due to the disease.

Comparing Multiple Groups
Since the data actually contain three groups (MM,
MGUS, and healthy groups), we could use analysis of
variance (ANOVA) to find genes that have an average
expression level that is different in at least one group.
Just as we used a nonparametric version of the t-test
(Wilcoxon rank sum test) in the two-group comparison,
we could also use a nonparametric version of ANOVA
(Kruskal-Wallis test) to analyze non-normal data from
more than two groups. Each of these tests produces
a p-value for the difference across the groups for
every single gene. Significant differences can then be
identified based on the magnitude of each p-value.

Classification
Sometimes the research question has to do with
predicting class membership in a set of data for which
the classes are already known, that is, classifying a new
sample into a known class. In this situation, we could
use past data to set up a logistic regression model that
can classify a future sample data point. One way to
test the accuracy of the model is to classify a subset of
points with known class membership that was not used
in building the model. These independent data values
will give unbiased information about the accuracy of
STATS 42
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the classification procedure. When applied to an entire
dataset, this procedure is called cross validation. The
algorithm for the cross validation procedure is:
1. Partition the data into k groups of the same size.
2. Remove the first group from the data and build
the model on the remaining k-1 groups.
3. Test the removed group of data using the above
model and record the predicted class
membership.
4. Repeat steps 2 and 3 for each of the k groups.
5. Compile the false positive and the false negative
rates as a measure of model accuracy.
Using logistic regression with expression level as
the explanatory variable and the disease groups (MM
vs. healthy, MM vs. MGUS, healthy vs. MGUS) as the
response variable, we can create models that predict the
classification of future observations into dichotomous
categories such as sick or healthy. The accuracy of
these three separate models was evaluated using cross
validation. The results are displayed in Table 3.

MM
Percentage
Correctly
Classified

Healthy

MM

MGUS

MGUS Normal

96.79% 84.44% 93.58% 38.10% 91.11% 71.43%

Table 3. Results from using logistic regression to predict class
membership (MM, MGUS, or Healthy). The effectiveness of the
model is evaluated using cross validation. Each entry in the table
is the percentage of samples correctly classified.

It is apparent from the results that logistic regression
using gene expression values can be used to discriminate
between the healthy group and the malignant groups,
but it is not useful for discriminating between the
two malignant groups (MM and MGUS). This lack of
discrimination is seen in the comparison of MM versus
MGUS where most of the MGUS samples (62%) were
incorrectly predicted to be from MM patients.
This and other discrimination methods for microarray
analyses have been compared using cross validation
prediction error rates (Hardin et al. 2004).

Clustering
Clustering is a process by which data can be
grouped without any preconceived knowledge of the
groupings or even of the number of groups. While
classification models are referred to as “supervised
learning,” clustering is sometimes referred to as
“unsupervised learning.” As with most techniques,
there are different clustering algorithms, yet many use
some type of metric to establish a distance between
two samples or two groups of samples. The concept in
clustering is that the closer two items are to each other,
the more likely they are related and should therefore be
grouped together.
8
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Clustering techniques provide a visual representation
of patterns in the data. Groupings or clusters can
illustrate relationships that may or may not be known
by the researcher. For example, a particular clustering
result may demonstrate what gene expressions are
useful for characterizing genes with known functions.
Or, a clustering result may lead to the discovery of
groups of genes that have similar expression patterns.
Clustering can also be performed on samples instead of
genes. When we cluster samples, we look for similar
genetic patterns in groups of individuals.
In hierarchical clustering, the first step is to link
the two closest samples. Subsequently, that pair is
compared to the remaining samples and either another
two samples are linked or the first pair (cluster) is linked
to a third sample based on which of these choices
represents a shorter distance. This process continues
until every sample in the data set is linked to another.
Figure 4 (see page 10) shows the sequential linkages
of a sample of patients in our Multiple Mylenoma
example. Each vertical line represents one sample. The
samples from healthy people are labeled “X” and the
samples from the MGUS patients are labeled “MGUS.”
The MM samples are not labeled.
We can see that the MM samples tend to cluster
together to the left and the healthy samples tend
to cluster to the right, while the MGUS samples are
dispersed throughout. This could indicate that maybe
some of the MGUS samples will develop into MM while
others of them will remain benign.
To illustrate the clustering process, figure 5 (see page
10) is a magnification of the grouping of predominantly
healthy patients on the right side of figure 4. For merges
of a pair of samples, the value on the y-axis represents
the Euclidean distance between the two samples.
Where two clusters are merged, the value on the y-axis
represents the average of the distances between each of
the samples in one cluster and each of the samples in
the other cluster. Notice that merges shown at the lower
portion of the graph are samples that are the closest to
each other (most similar), while merges shown at the
upper portion of the graph are samples that are the
farthest apart (least similar).
Figures 6 (see page 11) shows clusterings of samples
from only MM patients. We notice that there still appear
to be some groups of samples even though all of the
patients have the disease. This might indicate that some
of the samples are genetically related in such a way that
those patients would respond similarly to treatment.
Figure 7 (see page 11) shows the results of clustering
using a set of 50 completely randomized expression
values. Because the data are randomly distributed,
we should not expect to see any clustering pattern
Interestingly, however, we can see some possible
group, even though there should be no structure to the
data. But when we compare figures 6 and 7, the groupings of random values in figure 7 are less distinct t
han the groups of real values in figure 6. We can
also see that the distances between random values in
figure 7 are much longer than the distances between
real values in figure 6.
ASA

Consequently, because the clustering algorithm
forces some configuration, we must be careful in
deducing that there are significant relationships among
the samples. A statistician should use these clustering
methods carefully, especially when communicating with
nonstatisticians, so as not to overinterpret any apparent
structure in the data. Interpreting the groups within a
hierarchical cluster is somewhat subjective and does
not follow a formal structure of decision-making as in
hypothesis testing.
Other classification and clustering techniques
commonly used on microarray data include “nearest
shrunken centroid” classification (Tibshirani et al. 2002)
and “model-based clustering” (Yeung et al. 2001).

Advanced Techniques
Advanced techniques are often applied to microarray
data and new methods are constantly being developed
to better analyze the data. Some examples of advanced
techniques we frequently use include:
• Time Series Analysis – With time series analysis we
can observe trends over time for organisms like yeast,
for example, that change rapidly (Zhao et al. 2001).
• Partial Least Squares and Principal Component
Analysis—Both of these methods allow the analyst to
reduce the dimensions of the data in a meaningful
way. Since many data sets have hundreds of samples
with thousands of dimensions, it is important to reduce
the dimensions in a way that captures the signal while
discounting the noise (Nguyen and Rocke 2002; Yeung
and Ruzzo 2001; Bair and Tibshirani 2004).
• Discriminant Analysis—This is a way of
partitioning the data and can be used for classification
problems (Dudoit et al. 2002).
• Survival Analysis—This technique is used to
evaluate data with censored endpoints that are common
in medical studies. “Censoring” occurs when a patient
dies or for some other reason does not complete
the study. The Cox proportional hazards model—the
standard survival model—is not equipped to handle
thousands of explanatory variables and so variable
reduction techniques must be used to fit survival
analysis models (Pauler et al. 2004; Bair and Tibshirani
2004).

What Statistical Issues are Specific to
Microarray Analyses?
Many of the techniques used to analyze microarray
data are straightforward applications of well-known
methodology and some of the established procedures
can be modified to handle large data sets. However,
some issues cannot be dealt with using standard
statistical approaches and research is needed into new
techniques to address specific problems.
One problem with microarray data is that the
number of genes is almost always bigger than the
sample size. This type of sparse data makes inverting
covariance matrices impossible, which in turn forces
ASA

us to pare down the number of variables for methods
like regression analysis that use inverted covariance
matrices to calculate least squares estimates. Some data
reduction techniques have been developed, but there
is more work to be done to develop new methods for
ascertaining what set of variables would be the most
informative.
Because we often are interested in understanding
particular genes, we use gene-by-gene techniques like
t-tests, ANOVA, or regression analysis. Each time a
gene is judged to be significant according to one of
these tests, there is the risk of producing a Type I
error. If we were to set our significance level to α =
0.05 and run t-tests on 10,000 genes, we would expect
500 genes to test as significant, even if there is no signal
in the data. The problem of controlling for this type
of error in general has been studied widely (Benjamini
and Hochberg 1995) and is now being researched
in the specific context of microarray data (Storey, 2002).
Another problem is that microarray data do not
conform to the usual assumptions of many standard
statistical tests. The data themselves are in units of
fluorescence and are often highly skewed right and
can even be negative if a “background adjustment”
is needed when the background fluorescence is
brighter than the foreground fluorescence. Often log
transformations (with some ad hoc adjustment for
the negative values) give data that are moderately
symmetric. However, log-transformed microarray data
may still have highly unequal variances for which
many techniques (like ANOVA) are not robust.
Transformations and normalizations for microarray data
are being researched so that the results from standard
statistical analyses, based on the usual requirements, are
reliable (Durbin et al. 2002).

What Software is Available for Microarray
Analyses?
New software is constantly being developed to
perform analyses specifically for microarray data.
Because the technology is relatively new, much of the
software is being developed in academia and is freely
available. Below are summaries of a few of the most
commonly used software programs. The synopses are
based on my experience and not meant as endorsements
or condemnations of any of the software.
• Bioconductor: This is a free program that runs
in R. It is designed for statisticians who are researching
new techniques on microarray data. It is flexible, though
it does require basic programming knowledge of R or
S-Plus. Bioconductor also has multiple graphs and
features designed specifically for extracting information
from microarray data.
www.bioconductor.org
• SAM & PAM: Significance Analysis of Microarrays
(SAM) and Prediction Analysis of Microarrays (PAM) are
free software programs that add-in to Microsoft Excel
or R. SAM produces pictures and lists of genes that are
Continued on page 12
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Figure 4. Hierarchical clustering of 85 randomly selected MM, MGUS, and Healthy Samples.

Figure 5. Hierarchical clustering analysis of 24 samples from healthy patients.
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Figure 6. Hierarchical clustering analysis of 50 samples from MM patients.

Figure 7. Hierarchical clustering analysis of 50 random expression values.
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for multiple comparisons. However, it is not free and not
as flexible for statistical research as other programs.
www.sigenetics.com/GeneSpring/GeneSpring.html

Summary
For biologists, microarray technology has opened new
avenues to access a new world of knowledge quickly
and inexpensively. Never before has it been possible to
study so many genes simultaneously on so many samples.
However, any technology is limited by its ability to extract
information.
As statisticians, it is our role to ensure that the
information obtained from microarray experiments is
valid and interpreted appropriately. Many of the statistical
concepts from the last century are applicable to microarray
analysis, but we must also open our minds to new
techniques and methodologies that will be better suited for
this new generation of data. In this century, our contribution
to science will be to develop the analyticaltools that can
handle future generations of data yet to come.
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